Announcements Trials
Browse Landscape

Phase

Phase 2/3 2Phase EARLY_PHASE1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2FED 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Dysplasia 1Bowen's Disease 1

Interventions

Imiquimod 2relugolix 1nilutamide 1histrelin 1enzalutamide 1bicalutamide 1apalutamide 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1abiraterone 1Triptorelin Pamoate 1Thioctic Acid 1Prednisone 1Picibanil 1Methylprednisolone 1Leuprolide 1Goserelin 1Flutamide 1Androgen Antagonists 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × FED × Imiquimod × Clear all
NCT02130323 2017-06-27

Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix

United States Naval Medical Center, San Diego

Phase 2/3 Completed
22 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT00384124 2008-03-26

Topical Imiquimod for Bowen's Disease of the Head and Neck

Brooke Army Medical Center

Phase 2/3 Unknown
50 enrolled

Bowen's Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡